Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Ascendis Pharma Ads (ASND)

Ascendis Pharma Ads (ASND)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Ascendis Pharma Ads TUBORG BOULEVARD 12 HELLERUP G7 DK-2900 DNK

P: 45-7022-2244 F: 647-796-0067

Description:

Ascendis Pharma A/S is a biopharmaceutical company. The company's product pipeline consist of TransCon Human Growth Hormone, TransCon Treprostinil, TransCon Insulin, TransCon Peptide and TransCon Ranibizumab, which are in different clinical stage, for the treatments of hormone deficiency, endocrinology, central nervous system disorders, infectious diseases and diabetes. Its technology includes TransCon which develop prodrug therapies. Ascendis Pharma A/S is based in Denmark.

Key Statistics

Overview:

Market Capitalization, $K 4,259,005
Shares Outstanding, K 42,135
Annual Sales, $ 12,500 K
Annual Net Income, $ -153,640 K
Last Quarter Sales, $ 3,610 K
Last Quarter Net Income, $ -66,210 K
60-Month Beta 0.62
% of Insider Shareholders 40.00%
Float, K 25,281
% Float 60.00%

Growth:

1-Year Return 53.95%
3-Year Return 429.77%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 11/27/19
Earnings Per Share ttm -4.62
EPS Growth vs. Prev Qtr 0.71%
EPS Growth vs. Prev Year -112.12%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00

ASND Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -16.16
Price/Earnings to Growth N/A
Return-on-Equity (After Tax) -35.99
Return-on-Assets (Before Tax) -32.57
Profit Margin % -1,229.12
Net Margin % N/A
Debt/Equity 0.05
Price/Sales 339.62
Price/Cash Flow N/A
Price/Book 5.59
Book Value/Share 18.01
Interest Coverage -1,026.40
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar